Compare Revvity Inc (RVTY) vs SiTime Corporation (SITM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs SiTime Corporation — how do they compare? Revvity Inc trades at $110.1 (market cap $11.87B), while SiTime Corporation trades at $589 (market cap $16.63B). The key difference: SiTime Corporation is the larger of the two by market cap, and Revvity Inc pays a 0.26% dividend while SiTime Corporation pays none. Which is the better fit depends on your goals.
| RVTY | SITM | |
|---|---|---|
Market Cap | $11.87B | $16.63B |
Sector | Technology | Technology |
52-Week High | $117.75 | $901.60 |
52-Week Low | $82.26 | $190.16 |
Enterprise Value | $14.36B | $15.84B |
Dividend Yield | 0.26% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $106.44, down 3.37% today, with a bullish technical outlook despite near-term weakness. The company maintains stable revenue around $2.9B with consistent earnings beats, though valuation multiples appear elevated with a P/E of 51. Recent AI product launches and FDA clearances demonstrate innovation in life sciences and diagnostics. Analyst consensus remains positive with a $111.43 price target and no sell ratings among 29 covering firms.
The stock presents a growth opportunity with strong analyst support and technological innovation, but faces risks from margin pressure and China market exposure. Current levels near support at $105 offer potential entry, though the high P/E requires sustained earnings growth to justify valuation. Upcoming Q2 earnings on August 4, 2026 will be critical for near-term direction.
SITM trades at $555.15, showing minimal daily movement with a 0.03% gain. The stock faces technical headwinds with a bearish moving average signal, though RSI levels suggest potential oversold conditions. Fundamentally, the company demonstrates strong revenue growth and consistent earnings beats, but operates at a net loss with negative margins. Recent developments include the completed acquisition of Renesas' timing business and strong AI-driven demand, with Q2 2026 results due August 5, 2026.
Analyst consensus remains strongly bullish with a $825 price target representing 49% upside potential. Key opportunities include accelerating AI infrastructure demand and strategic acquisitions, while risks center on continued profitability challenges and high valuation multiples. The company's growth trajectory appears promising, but investors should monitor the transition to sustainable profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About SiTime Corporation
SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →
